TY  - CONF

T1  - The targeted Action on Interleukin-13 with Tralokinumab improved the Sleep in two randomized, double-blind, placebo-controlled Phase III Studies in Patients with atopic Dermatitis

JO  - JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

PY  - 2021/01/01

AU  - Simon JC

AU  - Barbarot S

AU  - Gooderham M

AU  - Simpson E

AU  - Kurbasic A

AU  - Olsen CK

AU  - Cork MJ

AU  - Silverberg JI

ED  - 

VL  - 19

SP  - 56

EP  - 56

Y2  - 2024/12/22

ER  -